» Articles » PMID: 35750512

Frequent Low-Dose Δ-Tetrahydrocannabinol in Adolescence Disrupts Microglia Homeostasis and Disables Responses to Microbial Infection and Social Stress in Young Adulthood

Abstract

Background: During adolescence, microglia are actively involved in neocortical maturation while concomitantly undergoing profound phenotypic changes. Because the teenage years are also a time of experimentation with cannabis, we evaluated whether adolescent exposure to the drug's psychotropic constituent, Δ-tetrahydrocannabinol (THC), might persistently alter microglia function.

Methods: We administered THC (5 mg/kg, intraperitoneal) once daily to male and female mice from postnatal day (PND) 30 to PND44 and examined the transcriptome of purified microglia in adult animals (PND70 and PND120) under baseline conditions or following either of two interventions known to recruit microglia: lipopolysaccharide injection and repeated social defeat. We used high-dimensional mass cytometry by time-of-flight to map brain immune cell populations after lipopolysaccharide challenge.

Results: Adolescent THC exposure produced in mice of both sexes a state of microglial dyshomeostasis that persisted until young adulthood (PND70) but receded with further aging (PND120). Key features of this state included broad alterations in genes involved in microglia homeostasis and innate immunity along with marked impairments in the responses to lipopolysaccharide- and repeated social defeat-induced psychosocial stress. The endocannabinoid system was also dysfunctional. The effects of THC were prevented by coadministration of either a global CB receptor inverse agonist or a peripheral CB neutral antagonist and were not replicated when THC was administered in young adulthood (PND70-84).

Conclusions: Daily low-intensity CB receptor activation by THC during adolescence may disable critical functions served by microglia until young adulthood with potentially wide-ranging consequences for brain and mental health.

Citing Articles

Cannabis use, oral dysbiosis, and neurological disorders.

Hazzard A, McCrorey M, Salman T, Johnson D, Luo Z, Fu X NeuroImmune Pharm Ther. 2025; 3(3-4):183-193.

PMID: 39741560 PMC: 11683879. DOI: 10.1515/nipt-2024-0012.


Cannabis use in youth is associated with chronic inflammation.

Power E, Mongan D, Healy C, Susai S, Focking M, Zammit S Psychol Med. 2024; :1-11.

PMID: 39648682 PMC: 11779551. DOI: 10.1017/S0033291724002848.


Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence.

Rodrigues R, Marques J, Kofalvi A Cells. 2024; 13(22).

PMID: 39594623 PMC: 11593331. DOI: 10.3390/cells13221875.


Post-weaning social isolation alters sociability in a sex-specific manner.

Myers T, Birmingham E, Rhoads B, McGrath A, Miles N, Schuldt C Front Behav Neurosci. 2024; 18:1444596.

PMID: 39267986 PMC: 11390411. DOI: 10.3389/fnbeh.2024.1444596.


Adolescent THC impacts on mPFC dopamine-mediated cognitive processes in male and female rats.

Martinez M, Vera V, Ruiz C, Floresco S, Mahler S Psychopharmacology (Berl). 2024; 242(2):309-326.

PMID: 39190156 DOI: 10.1007/s00213-024-06676-9.


References
1.
Levine A, Clemenza K, Rynn M, Lieberman J . Evidence for the Risks and Consequences of Adolescent Cannabis Exposure. J Am Acad Child Adolesc Psychiatry. 2017; 56(3):214-225. DOI: 10.1016/j.jaac.2016.12.014. View

2.
Stella N . Endocannabinoid signaling in microglial cells. Neuropharmacology. 2008; 56 Suppl 1:244-53. PMC: 2654419. DOI: 10.1016/j.neuropharm.2008.07.037. View

3.
Qiu P, Simonds E, Bendall S, Gibbs Jr K, Bruggner R, Linderman M . Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol. 2011; 29(10):886-91. PMC: 3196363. DOI: 10.1038/nbt.1991. View

4.
Mrdjen D, Pavlovic A, Hartmann F, Schreiner B, Utz S, Leung B . High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease. Immunity. 2018; 48(2):380-395.e6. DOI: 10.1016/j.immuni.2018.01.011. View

5.
Howlett A, Barth F, Bonner T, Cabral G, Casellas P, Devane W . International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002; 54(2):161-202. DOI: 10.1124/pr.54.2.161. View